Market Cap ₹78 Cr.
Stock P/E 9.7
P/B 2.2
Current Price ₹125
Book Value ₹ 56.6
Face Value 10
52W High ₹210.7
Dividend Yield 0%
52W Low ₹ 66.8
Founded in 1989, Everlon Financials Limited is a prominent player in the financial services sector, offering a range of services including loans, investment advisory, and financial consultancy. The company, established by Mr. Ramesh Jain, caters to individual borrowers, SMEs, and corporate clients. Everlon Financials' mission is to provide innovative and reliable financial solutions that meet the diverse needs of their clients. Promoted by Jain family, company has steadily expanded its services and market presence. The company's focus on quality, transparency, and ethical business practices has strengthened its reputation in the financial sector. Everlon Financials leverages technology and offers customer-centric solutions, ensuring they remain competitive and responsive to market demands. The company's commitment to excellence and ethical practices underpins its strong market position.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 5 | 0 | 1 | 4 | 2 | 3 | 5 | 3 | 1 |
Other Income | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Total Income | 0 | 5 | 0 | 1 | 4 | 2 | 3 | 5 | 3 | 4 |
Total Expenditure | 0 | 2 | 0 | 0 | 3 | -0 | -2 | 2 | 3 | -3 |
Operating Profit | 0 | 2 | 0 | 1 | 1 | 2 | 5 | 2 | 1 | 7 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | 2 | 0 | 1 | 1 | 2 | 5 | 2 | 1 | 7 |
Provision for Tax | 0 | 0 | 1 | 0 | 0 | -1 | 1 | 0 | 0 | 2 |
Profit After Tax | 0 | 2 | -1 | 1 | 1 | 2 | 4 | 2 | 0 | 4 |
Adjustments | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 2 | -1 | 1 | 1 | 2 | 4 | 2 | 0 | 4 |
Adjusted Earnings Per Share | 0.1 | 3.4 | -1.1 | 1.7 | 1.4 | 3.9 | 6 | 3.2 | 0.7 | 7.2 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 53 | 41 | 31 | 39 | 37 | 40 | 37 | 34 | 35 | 5 | 10 | 12 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Total Income | 53 | 41 | 31 | 39 | 37 | 40 | 37 | 34 | 35 | 5 | 10 | 15 |
Total Expenditure | 52 | 40 | 31 | 39 | 36 | 39 | 37 | 33 | 35 | 3 | 1 | 0 |
Operating Profit | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 2 | 1 | 2 | 9 | 15 |
Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 2 | 0 | 0 | 0 |
Profit Before Tax | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 2 | 2 | 9 | 15 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 |
Profit After Tax | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 2 | 1 | 8 | 10 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 2 | 1 | 8 | 10 |
Adjusted Earnings Per Share | 0.6 | 0.2 | 0.1 | 0.2 | 0.4 | -0.7 | 0.3 | 0.1 | 3.8 | 2.4 | 12.9 | 17.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 100% | -33% | -24% | -15% |
Operating Profit CAGR | 350% | 65% | 0% | 25% |
PAT CAGR | 700% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 72% | 46% | 56% | 25% |
ROE Average | 54% | 32% | 20% | 11% |
ROCE Average | 62% | 37% | 24% | 14% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 2 | 2 | 6 | 6 | 6 | 6 | 6 | 7 | 9 | 10 | 19 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 5 | 5 | 4 | 3 | 6 | 4 | 3 | 5 | 0 | 0 | 0 |
Total Liabilities | 11 | 10 | 11 | 10 | 12 | 11 | 10 | 12 | 9 | 10 | 20 |
Fixed Assets | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 0 | 0 | 0 |
Other Non-Current Assets | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 |
Total Current Assets | 5 | 5 | 7 | 6 | 9 | 7 | 6 | 8 | 8 | 10 | 18 |
Total Assets | 11 | 10 | 11 | 10 | 12 | 11 | 10 | 12 | 9 | 10 | 20 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Cash Flow from Operating Activities | 1 | 2 | -1 | 2 | -1 | 1 | 1 | -1 | 2 | -2 | -1 |
Cash Flow from Investing Activities | -0 | -0 | 1 | 0 | -0 | 0 | 0 | -1 | 3 | 2 | -0 |
Cash Flow from Financing Activities | -1 | -2 | -1 | -2 | 1 | -2 | -1 | 2 | -5 | -1 | 1 |
Net Cash Inflow / Outflow | -0 | 0 | -0 | -0 | -0 | -0 | 0 | -0 | 1 | -1 | -0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.62 | 0.18 | 0.14 | 0.24 | 0.41 | -0.7 | 0.28 | 0.15 | 3.75 | 2.4 | 12.91 |
CEPS(Rs) | 1.38 | 0.95 | 0.55 | 0.63 | 0.8 | -0.26 | 0.69 | 0.54 | 4.15 | 2.52 | 13.04 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 4.9 | 5.06 | 10.17 | 10.41 | 10.82 | 11.12 | 11.4 | 11.64 | 15.39 | 17.79 | 31.37 |
Core EBITDA Margin(%) | 2.29 | 2.74 | 1.21 | 1.72 | 2 | 0.32 | 1.59 | 4.46 | 1.05 | 39.49 | 89.44 |
EBIT Margin(%) | 1.77 | 2.11 | 2.43 | 1.35 | 1.66 | -0.21 | 1.06 | 1.83 | 7.28 | 40.9 | 89.87 |
Pre Tax Margin(%) | 0.58 | 0.22 | 0.3 | 0.44 | 0.79 | -0.99 | 0.43 | 0.88 | 6.59 | 40.73 | 89.68 |
PAT Margin (%) | 0.47 | 0.17 | 0.25 | 0.34 | 0.62 | -0.99 | 0.42 | 0.24 | 6.03 | 26.19 | 79.16 |
Cash Profit Margin (%) | 1.03 | 0.92 | 1 | 0.91 | 1.23 | -0.36 | 1.04 | 0.89 | 6.67 | 27.54 | 79.95 |
ROA(%) | 2.37 | 0.68 | 0.7 | 1.27 | 2.07 | -3.43 | 1.55 | 0.77 | 20.32 | 14.12 | 53.36 |
ROE(%) | 13.6 | 3.59 | 1.97 | 2.34 | 3.83 | -6.38 | 2.48 | 1.28 | 27.76 | 14.46 | 54.36 |
ROCE(%) | 10.24 | 9.22 | 7.59 | 5.45 | 6.19 | -0.82 | 4.3 | 6.35 | 26.06 | 22.57 | 61.7 |
Receivable days | 18.97 | 19.96 | 24.18 | 17.92 | 24.55 | 24.36 | 15.13 | 21.14 | 0 | 0 | 0 |
Inventory Days | 10.12 | 18.83 | 29.72 | 27.64 | 37.65 | 41.55 | 42.68 | 48.13 | 45.3 | 443.36 | 478.69 |
Payable days | 5.51 | 9.23 | 9.91 | 6.87 | 9.47 | 7.74 | 5.34 | 7.04 | 3.75 | 2.56 | 14.75 |
PER(x) | 13.08 | 71.73 | 76.3 | 69.71 | 30.84 | 0 | 0 | 76.95 | 10.25 | 15.35 | 5.67 |
Price/Book(x) | 1.66 | 2.54 | 1.01 | 1.61 | 1.16 | 1.3 | 0 | 0.98 | 2.5 | 2.07 | 2.33 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.19 | 0.29 | 0.33 | 0.31 | 0.32 | 0.29 | 0.21 | 0.31 | 0.52 | 3.99 | 4.48 |
EV/Core EBITDA(x) | 8.33 | 10.25 | 22.75 | 16.38 | 13.95 | 69.57 | 12.47 | 6.35 | 23.15 | 9.45 | 4.95 |
Net Sales Growth(%) | 11.13 | -23.17 | -24.52 | 26.67 | -6.48 | 8 | -5.75 | -8.84 | 2.76 | -85.28 | 96.39 |
EBIT Growth(%) | 5.02 | -8.69 | -12.94 | -29.8 | 15.07 | -113.78 | 573.63 | 57.06 | 308.79 | -17.37 | 331.6 |
PAT Growth(%) | 33.79 | -71.36 | 6.26 | 77.75 | 69.17 | -271.89 | 139.95 | -47.23 | 2443.91 | -36.07 | 493.6 |
EPS Growth(%) | 33.84 | -71.3 | -24.64 | 78.52 | 68.84 | -271.91 | 139.94 | -47.21 | 2443.05 | -36.07 | 438.27 |
Debt/Equity(x) | 3.79 | 3.6 | 0.84 | 0.52 | 0.77 | 0.55 | 0.36 | 0.66 | 0 | 0 | 0 |
Current Ratio(x) | 1.03 | 0.95 | 1.58 | 1.73 | 1.46 | 1.74 | 2.17 | 1.69 | 110.07 | 52.85 | 102.37 |
Quick Ratio(x) | 0.59 | 0.55 | 0.88 | 0.92 | 0.66 | 0.71 | 0.63 | 0.73 | 49.13 | 7.33 | 1.06 |
Interest Cover(x) | 1.49 | 1.11 | 1.14 | 1.49 | 1.9 | -0.27 | 1.68 | 1.93 | 10.51 | 244.79 | 478.22 |
Total Debt/Mcap(x) | 2.28 | 1.42 | 0.83 | 0.32 | 0.66 | 0.42 | 0 | 0.68 | 0 | 0 | 0 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 71.71 | 71.84 | 71.84 | 71.84 | 74.47 | 74.47 | 74.47 | 74.47 | 74.47 | 74.47 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 28.29 | 28.16 | 28.16 | 28.16 | 25.53 | 25.53 | 25.53 | 25.53 | 25.53 | 25.53 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.4 | 0.4 | 0.4 | 0.4 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.56 | 0.56 | 0.56 | 0.56 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About